BioCryst Pharmaceuticals | BCRX - 员工总数

金融业

USD

USD 557.85M

现金及等价物

USD 154.97M

USD 3.84M

USD 484.68M

USD 208.85M

USD 828.6M

股息收益率

0

USD 98.47M

USD 51.7M

536

EPS每股收益

USD 0.3

股本和储备

USD -454.29M

USD 214.41M

债务利息支出

USD 21.71M

USD -0.13

USD 395.4M

USD 1.85B

USD 78.4M

USD 119.79M

USD 98.47M

普通股股本

USD 255.27M

6.84

USD 248.02M

USD 218.25M

销售和管理费用

USD 63.98M

USD 6.06M

贸易债权人

USD 11.46M

应收帐款人

USD 110.76M

	员工	更改		日
Alnylam Pharmaceuticals	2.23K		130	2024-12
BioCryst Pharmaceuticals	536		5	2023-12
Chugai Pharma	7.78K		174	2024-12
Daiichi Sankyo	19.76K		1.04K	2025-12
DBV Technologies	USD 104		19	2023-12
Enanta Pharmaceuticals	145		15	2023-09
Gilead Sciences	17.6K		400	2024-12
GlaxoSmithKline	69.4K		20.7K	2022-12
Glaxosmithkline	GBP 69.4K		20.7K	2022-12
Incyte	2.62K		93	2024-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Karyopharm Therapeutics	325		60	2023-12
Neurocrine Biosciences	1.8K		400	2024-12
Novavax	1.54K		449	2023-12
PTC Therapeutics	939		49	2024-12
Regeneron Pharmaceuticals	13.45K		1.6K	2023-12
Roche Holding	103.61K		2.69K	2022-12
Sarepta Therapeutics	1.37K		58	2024-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
Vertex Pharmaceuticals	6.1K		700	2024-12